HEALTH NEWS

Study Title:

Some heartburn drugs may boost risk of heart attack, study finds

Study Abstract

A large data-mining study carried out by investigators at the Stanford University School of Medicine has linked a popular class of heartburn drugs to an elevated risk of heart attack.

Proton-pump inhibitors, or PPIs, are among the world’s most widely prescribed drugs, with $14 billion in annual sales. They are effective at lowering the acidity of the stomach, in turn preventing heartburn, a burning sensation in the chest that occurs when stomach acid rises up into the esophagus. In any given year, more than 20 million Americans — about one in every 14 — use PPIs such as omeprazole (trade name Prilosec) for heartburn, also known as acid reflux or gastroesophageal reflux disease.

Study Information

Some heartburn drugs may boost risk of heart attack, study finds

2015 June

Full Study

https://med.stanford.edu/news/all-news/2015/06/some-heartburn-drugs-may-boost-risk-of-heart-attack-study-finds.html